Table VIII.
Variable | CIH-L+CIH-E | CIH-L+CON-E | CON-L+CIH-E | CON-L+CON-E |
---|---|---|---|---|
IL-6, pg/ml | 187.94±20.36a–c | 154.08±17.93a | 125.93±13.20a | 86.51±10.68 |
TNF-α, pg/ml | 180.77±17.35a–c | 146.38±15.90a | 127.37±14.62a | 102.64±11.86 |
CRP, pg/ml | 253.35±25.89a–c | 190.28±16.72a | 158.44±15.20a | 108.95±9.54 |
NO, µM | 3.06±0.25a | 4.27±0.63a | 3.84±0.41a | 6.06±0.52 |
NOS, U/ml | 1.94±0.07a | 2.84±0.33a | 2.50±0.19a | 4.35±0.26 |
P<0.05 vs. CON-L+CON-E group
P<0.05 vs. CIH-L+CON-E group
P<0.05 vs. CON-L+CIH-E group. CIH, chronic intermittent hypoxia; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; CRP, C-reactive protein; NO, nitric oxide; NOS, nitric oxide synthase; CON, control; L, lymphocytes; E, endotheliocytes.